CrushSCI.com
170.5Average days
160Median days
18Fastest days
316Longest days
1552025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

18 days

Precision medicine approaches in diabetic cardiomyopathy: from molecular mechanisms to personalized therapeutic strategies

Authors
Vaibhavkumar Patel; Kinjal Patel; Bhakti Patel; Drashti Patel; Aarti KushwahaShow moreShow less
Affiliations
Head of Department of Pharmacology and Pharmacy Practice, Saraswati Institute of Pharmaceutical Science, Gandhinagar, Gujarat, India; Department of Pharmacy, Sumandeep Vidyapeeth, Vadodara, Gujarat, India; Department of Pharmacology and Pharmacy Practice, Saraswati Institute of Pharmaceutical Science, Gandhinagar, Gujarat, India; Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India; Clinical Research Co-ordinator, RSW Health, Ahmedabad, Gujarat, IndiaShow moreShow less
Source PDF DOI Publisher page
265 days

Electrophysiological remodeling in the hypertrophic cardiomyopathy MYBPC3 R943X mutant in human iPSC-derived cardiomyocytes and modulation by IKto-targeting drugs

Authors
Mena Abdelsayed; Efthimios Tim Gianitsos; Alice Yu; Mark MercolaShow moreShow less
Affiliations
Lankenau Institute for Medical Research, Wynnewood, PA, USA; Advanced Micro Devices, Inc., San Diego, CA, USA; OncoCardia Corporation, Belmont, CA, USA; Stanford Cardiovascular Institute, Stanford, CA, USAShow moreShow less
Source PDF DOI Publisher page
160 days

S-nitrosylation of CaMKII Cys273 suppresses CaMKII activation and mobility within cardiac myocytes

Authors
Chidera C. Alim; Wei-Lun Hsiao; Christopher Y. Ko; Julie Bossuyt; Donald M. BersShow moreShow less
Affiliations
Department of Pharmacology, University of California, Davis, Davis, CA, United States of AmericaShow moreShow less
Source PDF DOI Publisher page
142 days

Inhibition of CDK1 attenuates cardiac remodeling via suppression of fibroblast-derived TGF-β1

Authors
Taishi Yamamoto; Shouji Matsushima; Eri Noda; Kosuke Okabe; Masashi Sada; Nobuyuki Enzan; Yoshitomo Tsutsui; Ryo Miyake; Ryohei Nishimura; Takayuki Toyohara; Hiroko Deguchi Miyamoto; Akihito Ishikita; Soichiro Ikeda; Tomonori Tadokoro; Masataka Ikeda; Keisuke Shinohara; Toru Hashimoto; Daiki Setoyama; Yuya Kunisaki; Shintaro Kinugawa; Hiroyuki Tsutsui; Kohtaro AbeShow moreShow less
Affiliations
Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan; Division of Cardiovascular Medicine, Research Institute of Angiocardiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Clinical Laboratory, Kyushu University Hospital, Fukuoka, Japan; Department of Cardiovascular Medicine, NHO Fukuoka National Hospital, Fukuoka, JapanShow moreShow less
Source PDF DOI Publisher page
95 days

Multi-omic analysis reveals maturation programs in human pluripotent stem cell-derived cardiomyocytes during long-term culture

Authors
Austin K. Feeney; Aaron D. Simmons; Elizabeth F. Bayne; Yanlong Zhu; Chanhyung Park; Claire J. Peplinski; Fathima Shabnam; Xiaotian Zhang; Jianhua Zhang; Melissa R. Pergande; Timothy J. Kamp; Ying Ge; Sean P. PalecekShow moreShow less
Affiliations
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA; Medical Scientist Training Program, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA; Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA; Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI 53705, USA; Human Proteomics Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USAShow moreShow less
Source PDF DOI Publisher page
224 days

Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3+ inflammatory cells

Authors
Lu Liu; Wenhui Niu; Yumeng Jia; Qun Zhang; Tangyu Dai; Dingwei Li; Shuang Song; Yan Ma; Jingjing Wang; Huanling Yu; Guoyou Liu; Jie Du; Lei WangShow moreShow less
Affiliations
Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beijing 100069, China; Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaomin Lane, Dongcheng District, Beijing 100730, China; National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China; Department of Laboratory Animals, Capital Medical University, Beijing 100069, China; Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; Institute for Biological Therapy, Henan Academy of Medical Science, Zhengzhou, Henan 451163, China; Beijing Anzhen Hospital, Capital Medical University; The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education; Beijing Collaborative Innovative Research Center for Cardiovascular Diseases; Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China; The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY take to review a manuscript?

As of 2026-11-13, CrushSCI has 15 complete review records for JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. The fastest paper went from submission to acceptance in 18 days (Precision medicine approaches in diabetic cardiomyopathy: from molecular mechanisms to personalized therapeutic strategies, received 2026-10-02, accepted 2026-10-20); the slowest took 316 days. The average is 170.5 days and the median is 160 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.